Schizophrenia Research
Volume 84, Issue 2 , Pages 187-193 , June 2006

Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications

  • Martin Debbané

      Affiliations

    • Service Médico-Pédagogique, Department of Psychiatry, University of Geneva School of Medicine, 16-18 Boulevard St-Georges, Case Postale 50, 1211 Geneva 8, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 22 327 43 03; fax: +41 22 327 43 20.
    • ,
  • Bronwyn Glaser

      Affiliations

    • Service Médico-Pédagogique, Department of Psychiatry, University of Geneva School of Medicine, 16-18 Boulevard St-Georges, Case Postale 50, 1211 Geneva 8, Switzerland
    • ,
  • Melissa K. David

      Affiliations

    • Service Médico-Pédagogique, Department of Psychiatry, University of Geneva School of Medicine, 16-18 Boulevard St-Georges, Case Postale 50, 1211 Geneva 8, Switzerland
    • ,
  • Carl Feinstein

      Affiliations

    • Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Stanford University Medical School, Switzerland
    • ,
  • Stephan Eliez

      Affiliations

    • Service Médico-Pédagogique, Department of Psychiatry, University of Geneva School of Medicine, 16-18 Boulevard St-Georges, Case Postale 50, 1211 Geneva 8, Switzerland
    • Department of Genetic Medicine and Development, University of Geneva School of Medicine, Switzerland

Received 28 July 2005 ,Revised 27 January 2006 ,Accepted 27 January 2006.

References 

  1. Achenbach TM. Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington, VT: University of Vermont. Department of Psychiatry; 1991;
  2. Achenbach TM, Rescorla LA. Manual for the Aseba adult forms and profiles. Burlington: University of Vermont. Res. Cent. Children, Youth, Families. 2003;
  3. Allen DN, Frantom LV, Strauss GP, van Kammen DP. Differential patterns of premorbid academic and social deterioration in patients with schizophrenia. Schizophr. Res. 2005;75(2–3):389–397
  4. Baker KD, Skuse DH. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br. J. Psychiatry. 2005;186:115–120
  5. Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am. J. Psychiatry. 2003;160(9):1580–1586
  6. Bearden CE, Woodin MF, Wang PP, Moss E, McDonald-McGinn D, Zackai E, et al. The neurocognitive phenotype of the 22q11.2 deletion syndrome: selective deficit in visual–spatial memory. J. Clin. Exp. Neuropsychol. 2001;23(4):447–464
  7. Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am. J. Psychiatry. 2005;162(1):71–78
  8. Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Arch. Gen. Psychiatry. 2002;59(5):449–456
  9. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. J. Abnorm. Psychology. 1994;103(2):171–183
  10. Cohen, M.J., 1997, translated in French 2001. Cms: Echelle de mémoire pour enfants. Manual: The Psychological Corporation and ECPA, Les Editions du Centre de Psychologie Appliquée).
  11. Davalos DB, Compagnon N, Heinlein S, Ross RG. Neuropsychological deficits in children associated with increased familial risk for schizophrenia. Schizophr. Res. 2004;67(2–3):123–130
  12. David AS, Malmberg A, Brandt L, Allebeck P, Lewis G. Iq and risk for schizophrenia: a population-based cohort study. Psychol. Med. 1997;27(6):1311–1323
  13. Erlenmeyer-Kimling L, Rock D, Roberts SA, Janal M, Kestenbaum C, Cornblatt B. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am. J. Psychiatry. 2000;157(9):1416–1422
  14. First MB, Opler LA, Hamilton RM, Linder J, Linfield LS, Silver JM. Evaluation in an inpatient setting of dtree, a computer-assisted diagnostic assessment procedure. Compr. Psychiatry. 1993;34(3):171–175
  15. Frith CD, Done DJ. Towards a neuropsychology of schizophrenia. Br. J. Psychiatry. 1988;153:437–443
  16. Glaser, B., Debbané, M., Hinard, C., Morris, M.A., Dahoun, S.P., Antonarakis, S.E., et al., in press. No evidence for an effect of comt val158met genotype on executive function in patients with 22q11 deletion syndrome, 22q11.2ds. American J Psychiatry.
  17. Gothelf D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C. Comt genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat. Neurosci. 2005;8(11):1500–1502
  18. Johnstone EC, Ebmeier KP, Miller P, Owens DG, Lawrie SM. Predicting schizophrenia: findings from the Edinburgh high-risk study. Br. J. Psychiatry. 2005;186:18–25
  19. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. U. S. A. 1995;92(17):7612–7616
  20. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version, K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psych. 1997;36(7):980–988
  21. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-o-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6(3):243–250
  22. Miller P, Byrne M, Hodges A, Lawrie SM, Johnstone EC. Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the Edinburgh high risk study. Psychol. Med. 2002;32(1):173–179
  23. Miller P, Byrne M, Hodges A, Lawrie SM, Owens DG, Johnstone EC. Schizotypal components in people at high risk of developing schizophrenia: early findings from the Edinburgh high-risk study. Br. J. Psychiatry. 2002;180:179–184
  24. Murphy KC. Annotation: velo-cardio-facial syndrome. J. Child Psychol. Psychiatry. 2005;46(6):563–571
  25. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry. 1999;56(10):940–945
  26. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch. Gen. Psychiatry. 2000;57(11):1053–1058
  27. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. Late-onset psychosis in the velo-cardio-facial syndrome. Am. J. Med. Genet. 1992;42(1):141–142
  28. Sparrow SS, Balla DA, Cicche HV. Vineland adaptive behavior scales-interview edition survey form manual. Circle Pines, MN: American Guidance Service Inc.; 1984;
  29. Wechsler D. Wechsler Intelligence Scale for Children-third edition, Manual. San Antonio: The Psychological Corporation; 1991;
  30. Wechsler D. Wechsler Adult Intelligence Scale-third edition. Administration and Scoring Manual. San Antonio: The Psychological Corporation; 1997;
  31. Wechsler, D., 1997. French translation 2001. Mem-iii: Echelle clinique de mémoire de wechsler-3ème édition. Manual: The Psychological Corporation and ECPA.

PII: S0920-9964(06)00064-8

doi: 10.1016/j.schres.2006.01.019

Schizophrenia Research
Volume 84, Issue 2 , Pages 187-193 , June 2006

Article Tools